Skip to main content

STATE STREET CORP

Position in BTAI — BioXcel Therapeutics, Inc.

CIK 93751 BOSTON, MA

Position in BTAI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$123,438
+$22,290 QoQ
Shares Held
92,118
+45.7% QoQ
Ownership
0.298%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 40 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority Sole 67.93026335786708.ToString("F0")% Shared 0.ToString("F0")% None 32.069736642132916.ToString("F0")%

Common Shares in BTAI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

STATE STREET CORP holds $7,512,717,333 across 54 Drug Manufacturers - Specialty & Generic names. BTAI ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BTAI

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $123,438 92,118
2025-12-31 $101,148 63,218
2025-09-30 $134,958 52,718